Global Pharmaceutical Policy

1. Front Matter

   Pages i-xviii

   PDF

2. Medicines Safety in the Globalized Context

   • Rabia Hussain, Mohamed Azmi Hassali, Zaheer-Ud-Din Babar

   Pages 1-28

3. Managing the Pharmaceutical Supply Chain—To Sustainability and Beyond

   • Liz Breen, Marina Papalexi, Ying Xie

   Pages 29-52

4. Generic Medicines and Biosimilars: Impact on Global Pharmaceutical Policy

   • Mohamed Izham Mohamed Ibrahim, Ahmed Awaisu

   Pages 53-72

5. Global Access to Cancer Medicines

   • Hye-Young Kwon, Yujeong Kim

   Pages 73-97

6. Medicines Pricing: Limitations of Existing Policies and New Models

   • Sabine Vogler

   Pages 99-137

7. Pharmacy Practice and Policy Research in Pakistan: A Review of Literature Between 2014 and 2019

   • Iram Malik, Muhammad Atif, Shane L. Scahill, Zaheer-Ud-Din Babar

   Pages 139-175

8. Promoting Access to Cancer Medicines in Mexico: Seguro Popular Key Policy Components

   • Daniela Moye-Holz, Anahí Dreser, Octavio Gómez-Dantés, Veronika J. Wirtz

   Pages 177-222

9. Access to Medicines: Case Studies from Russia and Kyrgyzstan

   • Liliya Eugenevna Ziganshina, Chinara M. Razzakova, Syed Shahzad Hasan, Zaheer-Ud-Din Babar

   Pages 223-246

10. Access and Use of Medicines in Ukraine

    • Grintsova Olga, Zaheer-Ud-Din Babar

    Pages 247-260

11. Public Participation in Access to Medicines

    • Sofia Crisóstomo, Filipa Alves da Costa

    Pages 261-291

12. Pharmaceutical Policy and Practice Research: A Review of Studies in China

    • Caijun Yang, Amna Saeed, Khezar Hayat, Krizzia-Mae Lambojon, Ali Hassan Gillani, Yu Fang

    Pages 293-308

13. Access to Vaccines and Immunization Programme

    • Suthira Taychakhoonavudh

    Pages 309-330

14. Global Antibiotics Use and Resistance

    • Mamoon Aldeyab, José-María López-Lozano, Ian M. Gould

    Pages 331-344

15. Medicines Access, Use and Pharmaceutical Health System Issues: Reflections, Thoughts and Points to Consider

    • Zaheer-Ud-Din Babar, Shane L. Scahill

    Pages 345-365

Medicines are vital in improving patient health outcomes and pharmaceutical policy is a fundamental component of any health system. However, the global pharmaceutical policy is ever-evolving and data and quality ‘research-based information’ in this field are scarce. This book fills this gap and provides up-to-date empirical information and evidence-based synthesis. It focuses on pertinent key issues in global pharmaceutical policy including medicines safety, generic medicines, pharmaceutical supply chain, medicines financing, access and affordability of medicines, rational use of medicines, pharmacy health services research and access to vaccines and biological products. Featuring policy case studies from varied countries such as Mexico, Russia, China, Kyrgyzstan, and Pakistan, this book comprises a valuable and comprehensive resource for students, funders, policymakers, academics, and researchers interested in this field.

• Pharmaceutical policy
• counterfeit medicines
• medicines promotion
• generic medicines
• pharmacy health services
• pharmacoeconomics
• pharmacovigilance
• pricing and affordability of medicines
• Socio-behavioral aspects of health and pharmacy
• Pharmaceutical promotion
• Pharmacoeconomics and medicines expenditure
• Drug pricing and financing
• Rational drug use

• Centre for Pharmaceutical Policy and Practice Research, University of Huddersfield, Huddersfield, UK

  Zaheer-Ud-Din Babar

Zaheer-Ud-Din Babar is Professor in Medicines and Healthcare and the Director of the Centre of Pharmaceutical Policy and Practice Research at the University of Huddersfield, United Kingdom. He has an in-depth understanding of global health, pharmacy systems and pharmaceutical policy and has worked in Malaysia, New Zealand, Pakistan and the UK.

Policies and ethics